GOVXGeoVax Labs, Inc.

Nasdaq geovax.com


$ 1.46 $ -0.05 (-3.4 %)    

Friday, 26-Apr-2024 09:34:30 EDT
QQQ $ 432.54 $ -0.65 (-0.15 %)
DIA $ 383.04 $ -0.20 (-0.05 %)
SPY $ 509.94 $ -0.32 (-0.06 %)
TLT $ 88.78 $ 0.12 (0.14 %)
GLD $ 216.52 $ 0.47 (0.22 %)
$ 1.42
$ 1.46
$ 0.00 x 0
$ 0.00 x 0
$ 1.46 - $ 1.46
$ 1.40 - $ 11.54
37,455
na
3.08M
$ -23.67
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-29-2024 12-31-2023 10-K
2 11-08-2023 09-30-2023 10-Q
3 08-09-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 03-23-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-03-2022 06-30-2022 10-Q
8 04-27-2022 03-31-2022 10-Q
9 03-09-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-11-2021 06-30-2021 10-Q
12 05-06-2021 03-31-2021 10-Q
13 03-23-2021 12-31-2020 10-K
14 11-05-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-05-2020 03-31-2020 10-Q
17 03-24-2020 12-31-2019 10-K
18 11-07-2019 09-30-2019 10-Q
19 08-13-2019 06-30-2019 10-Q
20 05-13-2019 03-31-2019 10-Q
21 03-26-2019 12-31-2018 10-K
22 11-08-2018 09-30-2018 10-Q
23 08-07-2018 06-30-2018 10-Q
24 05-03-2018 03-31-2018 10-Q
25 03-23-2018 12-31-2017 10-K
26 11-09-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 05-12-2017 03-31-2017 10-Q
29 03-24-2017 12-31-2016 10-K
30 11-14-2016 09-30-2016 10-Q
31 08-05-2016 06-30-2016 10-Q
32 05-04-2016 03-31-2016 10-Q
33 03-16-2016 12-31-2015 10-K
34 11-12-2015 09-30-2015 10-Q
35 08-04-2015 06-30-2015 10-Q
36 05-14-2015 03-31-2015 10-Q
37 03-20-2015 12-31-2014 10-K
38 11-12-2014 09-30-2014 10-Q
39 08-08-2014 06-30-2014 10-Q
40 05-02-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

https://twitter.com/DrTedros/status/1778423967105139108  

 geovax-to-present-data-on-geo-cm04s1-a-next-generation-covid-19-vaccine-at-the-world-vaccine-congress

GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious...

 geovax-labs-inc-files-for-mixed-shelf-of-up-to-100m

– SEC Filing

 geovax-labs-q4-earnings-insights
Geovax Labs: Q4 Earnings Insights
02/29/2024 21:10:39

 geovax-labs-q4-2023-gaap-eps-3940-misses-2780-estimate

Geovax Labs (NASDAQ:GOVX) reported quarterly losses of $(3.940) per share which missed the analyst consensus estimate of $(2.78...

 earnings-scheduled-for-february-29-2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

 earnings-outlook-for-geovax-labs
Earnings Outlook For Geovax Labs
02/28/2024 19:02:14

 inmed-pharmaceuticals-and-2-other-penny-stocks-insiders-are-buying

The Dow Jones index closed higher by over 450 points on Thursday. When insiders purchase or sell shares, it indicates their con...

 geovax-announces-multiple-actions-by-global-patent-offices-strengthening-the-companys-intellectual-property-assets-intellectual-property-assets-strengthened-for-cancer-immunotherapy-program-and-for-marburg-virus-and-hiv-vaccines

Intellectual Property Assets Strengthened for Cancer Immunotherapy Programand for Marburg Virus and HIV VaccinesATLANTA, GA, Fe...

 geovax-reports-interim-data-from-phase-2-clinical-trial-of-geo-cm04s1-as-universal-covid-19-vaccine-booster

Results Demonstrate Potential Protective Immunity Against Multiple SARS-CoV-2 Variants

 geovax-announces-issuance-of-malaria-vaccine-patent-patent-covers-multiple-component-vaccine-for-both-prevention-and-treatment

Patent Covers Multiple Component Vaccine for Both Prevention and Treatment ATLANTA, GA, Jan. 03, 2024 (GLOBE NEWSWIRE) -- via N...

Core News & Articles

The Dow Jones index closed higher by over 150 points on Tuesday. When insiders purchase or sell shares, it indicates their conf...

 geovax-expands-rights-under-nih-covid-19-license-to-include-mpox-and-smallpox-financial-terms-of-the-license-agreement-were-not-disclosed

GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION